$BCP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BALCHEM CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in BALCHEM CORP. Get notifications about new insider transactions in BALCHEM CORP for free.
Page: < prev 1 2 3 4 5 6 7 8 ... 9 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 05 2013 | BCP | BALCHEM CORP | FITZPATRICK FRANK | CFO | Sell | S | 47.81 | 11,003 | 526,053 | 55,902 | 66.9 K to 55.9 K (-16.45 %) |
Sep 05 2013 | BCP | BALCHEM CORP | FITZPATRICK FRANK | CFO | Buy | M | 9.21 | 11,003 | 101,338 | 66,905 | 55.9 K to 66.9 K (+19.68 %) |
Aug 28 2013 | BCP | BALCHEM CORP | BENDURE RICHARD ALLEN | Chief Operating Off ... | Payment of Exercise | F | 48.22 | 616 | 29,704 | 18,118 | 18.7 K to 18.1 K (-3.29 %) |
Aug 21 2013 | BCP | BALCHEM CORP | ROSSI DINO A | President & CEO | Sell | S | 50.01 | 7,500 | 375,075 | 136,727 | 144.2 K to 136.7 K (-5.20 %) |
Aug 21 2013 | BCP | BALCHEM CORP | ROSSI DINO A | President & CEO | Buy | M | 9.21 | 7,500 | 69,075 | 144,227 | 136.7 K to 144.2 K (+5.49 %) |
Aug 21 2013 | BCP | BALCHEM CORP | ROSSI DINO A | President & CEO | Sell | S | 50.35 | 7,500 | 377,625 | 136,727 | 144.2 K to 136.7 K (-5.20 %) |
Aug 21 2013 | BCP | BALCHEM CORP | ROSSI DINO A | President & CEO | Buy | M | 9.21 | 7,500 | 69,075 | 144,227 | 136.7 K to 144.2 K (+5.49 %) |
Aug 09 2013 | BCP | BALCHEM CORP | LUDWIG DAVID F | VP/Gen Mgr/ARC Spec ... | Sell | S | 52.54 | 24,538 | 1,289,227 | 32,535 | 57.1 K to 32.5 K (-42.99 %) |
Aug 09 2013 | BCP | BALCHEM CORP | LUDWIG DAVID F | VP/Gen Mgr/ARC Spec ... | Buy | M | 5.85 | 24,538 | 143,547 | 57,073 | 32.5 K to 57.1 K (+75.42 %) |
Aug 07 2013 | BCP | BALCHEM CORP | TELEVANTOS JOHN Y | Director | Sell | S | 52.75 | 566 | 29,857 | 45,257 | 45.8 K to 45.3 K (-1.24 %) |
Aug 07 2013 | BCP | BALCHEM CORP | TELEVANTOS JOHN Y | Director | Sell | S | 52.80 | 4,434 | 234,115 | 45,823 | 50.3 K to 45.8 K (-8.82 %) |
Aug 02 2013 | BCP | BALCHEM CORP | FITZPATRICK FRANK | CFO | Sell | S | 50.43 | 13,500 | 680,805 | 55,902 | 69.4 K to 55.9 K (-19.45 %) |
Aug 02 2013 | BCP | BALCHEM CORP | FITZPATRICK FRANK | CFO | Sell | S | 9.21 | 8,698 | 80,109 | 69,402 | 78.1 K to 69.4 K (-11.14 %) |
Aug 02 2013 | BCP | BALCHEM CORP | FITZPATRICK FRANK | CFO | Buy | M | 5.85 | 4,802 | 28,092 | 60,704 | 55.9 K to 60.7 K (+8.59 %) |
Jul 22 2013 | BCP | BALCHEM CORP | ROSSI DINO A | President & CEO | Sell | S | 47.05 | 7,500 | 352,875 | 136,727 | 144.2 K to 136.7 K (-5.20 %) |
Jul 22 2013 | BCP | BALCHEM CORP | ROSSI DINO A | President & CEO | Buy | M | 9.21 | 7,500 | 69,075 | 144,227 | 136.7 K to 144.2 K (+5.49 %) |
Jul 22 2013 | BCP | BALCHEM CORP | ROSSI DINO A | President & CEO | Sell | S | 47.03 | 7,500 | 352,725 | 136,727 | 144.2 K to 136.7 K (-5.20 %) |
Jul 22 2013 | BCP | BALCHEM CORP | ROSSI DINO A | President & CEO | Buy | M | 9.21 | 7,500 | 69,075 | 144,227 | 136.7 K to 144.2 K (+5.49 %) |
Jul 16 2013 | BCP | BALCHEM CORP | BENDURE RICHARD ALLEN | Chief Operating Off ... | Payment of Exercise | F | 47.13 | 616 | 29,032 | 18,734 | 19.4 K to 18.7 K (-3.18 %) |
Jul 03 2013 | BCP | BALCHEM CORP | FITZPATRICK FRANK | CFO | Sell | S | 45.21 | 13,500 | 610,335 | 55,902 | 69.4 K to 55.9 K (-19.45 %) |
Jul 03 2013 | BCP | BALCHEM CORP | FITZPATRICK FRANK | CFO | Buy | M | 5.85 | 13,500 | 78,975 | 69,402 | 55.9 K to 69.4 K (+24.15 %) |
Jun 21 2013 | BCP | BALCHEM CORP | ROSSI DINO A | President & CEO | Sell | S | 44.83 | 7,500 | 336,225 | 136,727 | 144.2 K to 136.7 K (-5.20 %) |
Jun 21 2013 | BCP | BALCHEM CORP | ROSSI DINO A | President & CEO | Buy | M | 9.21 | 7,500 | 69,075 | 144,227 | 136.7 K to 144.2 K (+5.49 %) |
Jun 21 2013 | BCP | BALCHEM CORP | ROSSI DINO A | President & CEO | Sell | S | 46.14 | 7,500 | 346,050 | 136,727 | 144.2 K to 136.7 K (-5.20 %) |
Jun 21 2013 | BCP | BALCHEM CORP | ROSSI DINO A | President & CEO | Buy | M | 9.21 | 7,500 | 69,075 | 144,227 | 136.7 K to 144.2 K (+5.49 %) |
Jun 19 2013 | BCP | BALCHEM CORP | WEDRAL ELAINE R | Director | Sell | S | 46.00 | 4,488 | 206,448 | 48,757 | 53.2 K to 48.8 K (-8.43 %) |
Jun 19 2013 | BCP | BALCHEM CORP | WEDRAL ELAINE R | Director | Buy | M | 7.32 | 4,488 | 32,852 | 53,245 | 48.8 K to 53.2 K (+9.20 %) |
Jun 14 2013 | BCP | BALCHEM CORP | WEDRAL ELAINE R | Director | Sell | S | 45.96 | 4,000 | 183,824 | 48,757 | 52.8 K to 48.8 K (-7.58 %) |
Jun 14 2013 | BCP | BALCHEM CORP | WEDRAL ELAINE R | Director | Buy | M | 7.32 | 4,000 | 29,280 | 52,757 | 48.8 K to 52.8 K (+8.20 %) |
Jun 07 2013 | BCP | BALCHEM CORP | PUTNAM DANA E. | V P & General Mange ... | Sell | S | 47.25 | 1,845 | 87,174 | 44,716 | 46.6 K to 44.7 K (-3.96 %) |
Jun 07 2013 | BCP | BALCHEM CORP | PUTNAM DANA E. | V P & General Mange ... | Buy | M | 29.06 | 1,845 | 53,616 | 46,561 | 44.7 K to 46.6 K (+4.13 %) |
Jun 07 2013 | BCP | BALCHEM CORP | PUTNAM DANA E. | V P & General Mange ... | Sell | S | 47.25 | 12,300 | 581,160 | 44,716 | 57 K to 44.7 K (-21.57 %) |
Jun 07 2013 | BCP | BALCHEM CORP | PUTNAM DANA E. | V P & General Mange ... | Buy | M | 32.21 | 12,300 | 396,183 | 57,016 | 44.7 K to 57 K (+27.51 %) |
Jun 07 2013 | BCP | BALCHEM CORP | PUTNAM DANA E. | V P & General Mange ... | Sell | S | 47.25 | 22,500 | 1,063,098 | 44,716 | 67.2 K to 44.7 K (-33.47 %) |
Jun 07 2013 | BCP | BALCHEM CORP | PUTNAM DANA E. | V P & General Mange ... | Buy | M | 21.39 | 22,500 | 481,275 | 67,216 | 44.7 K to 67.2 K (+50.32 %) |
Jun 04 2013 | BCP | BALCHEM CORP | FITZPATRICK FRANK | CFO | Sell | S | 47.90 | 13,500 | 646,610 | 55,902 | 69.4 K to 55.9 K (-19.45 %) |
Jun 04 2013 | BCP | BALCHEM CORP | FITZPATRICK FRANK | CFO | Buy | M | 5.85 | 13,500 | 78,975 | 69,402 | 55.9 K to 69.4 K (+24.15 %) |
May 13 2013 | BCP | BALCHEM CORP | Houston Matthew David | General Counsel/Sec ... | Sell | S | 43.16 | 41,229 | 1,779,444 | 25,316 | 66.5 K to 25.3 K (-61.96 %) |
May 13 2013 | BCP | BALCHEM CORP | Houston Matthew David | General Counsel/Sec ... | Buy | M | 21.39 | 6,900 | 147,591 | 66,545 | 59.6 K to 66.5 K (+11.57 %) |
May 13 2013 | BCP | BALCHEM CORP | Houston Matthew David | General Counsel/Sec ... | Buy | M | 17.28 | 9,000 | 155,520 | 59,645 | 50.6 K to 59.6 K (+17.77 %) |
May 13 2013 | BCP | BALCHEM CORP | Houston Matthew David | General Counsel/Sec ... | Buy | M | 13.61 | 15,000 | 204,150 | 50,645 | 35.6 K to 50.6 K (+42.08 %) |
May 13 2013 | BCP | BALCHEM CORP | Houston Matthew David | General Counsel/Sec ... | Buy | M | 11.87 | 6,750 | 80,123 | 35,645 | 28.9 K to 35.6 K (+23.36 %) |
May 13 2013 | BCP | BALCHEM CORP | Houston Matthew David | General Counsel/Sec ... | Buy | M | 9.21 | 16,875 | 155,419 | 28,895 | 12 K to 28.9 K (+140.39 %) |
May 03 2013 | BCP | BALCHEM CORP | FITZPATRICK FRANK | CFO | Sell | S | 42.64 | 10,506 | 447,976 | 55,902 | 66.4 K to 55.9 K (-15.82 %) |
May 03 2013 | BCP | BALCHEM CORP | FITZPATRICK FRANK | CFO | Buy | M | 5.85 | 10,506 | 61,460 | 66,408 | 55.9 K to 66.4 K (+18.79 %) |
May 03 2013 | BCP | BALCHEM CORP | FITZPATRICK FRANK | CFO | Sell | S | 42.33 | 2,994 | 126,736 | 55,902 | 58.9 K to 55.9 K (-5.08 %) |
May 03 2013 | BCP | BALCHEM CORP | FITZPATRICK FRANK | CFO | Buy | M | 5.85 | 2,994 | 17,515 | 58,896 | 55.9 K to 58.9 K (+5.36 %) |
Apr 02 2013 | BCP | BALCHEM CORP | FITZPATRICK FRANK | CFO | Sell | S | 42.92 | 13,500 | 579,420 | 55,902 | 69.4 K to 55.9 K (-19.45 %) |
Apr 02 2013 | BCP | BALCHEM CORP | FITZPATRICK FRANK | CFO | Buy | M | 5.85 | 15,823 | 92,565 | 69,271 | 53.4 K to 69.3 K (+29.60 %) |
Mar 18 2013 | BCP | BALCHEM CORP | PUTNAM DANA E. | VP and GM, Animal N ... | Sell | S | 42.50 | 27,000 | 1,147,500 | 44,716 | 71.7 K to 44.7 K (-37.65 %) |
Mar 18 2013 | BCP | BALCHEM CORP | PUTNAM DANA E. | VP and GM, Animal N ... | Buy | M | 17.28 | 27,000 | 466,560 | 71,716 | 44.7 K to 71.7 K (+60.38 %) |
Feb 21 2013 | BCP | BALCHEM CORP | ROSSI DINO A | President & CEO | Option Exercise | A | 38.10 | 22,069 | 840,829 | 0 | |
Feb 21 2013 | BCP | BALCHEM CORP | ROSSI DINO A | President & CEO | Sell | S | 36.28 | 14,925 | 541,479 | 136,851 | 151.8 K to 136.9 K (-9.83 %) |
Feb 21 2013 | BCP | BALCHEM CORP | ROSSI DINO A | President & CEO | Buy | M | 5.85 | 14,925 | 87,311 | 151,776 | 136.9 K to 151.8 K (+10.91 %) |
Feb 21 2013 | BCP | BALCHEM CORP | ROSSI DINO A | President & CEO | Sell | S | 37.88 | 34,569 | 1,309,474 | 136,851 | 171.4 K to 136.9 K (-20.17 %) |
Feb 21 2013 | BCP | BALCHEM CORP | ROSSI DINO A | President & CEO | Buy | M | 5.85 | 34,569 | 202,229 | 171,420 | 136.9 K to 171.4 K (+25.26 %) |
Feb 21 2013 | BCP | BALCHEM CORP | ROSSI DINO A | President & CEO | Grant | A | 0.00 | 5,757 | 0 | 136,851 | 131.1 K to 136.9 K (+4.39 %) |
Mar 04 2013 | BCP | BALCHEM CORP | BENDURE RICHARD ALLEN | Chief Operating Off ... | Payment of Exercise | F | 41.28 | 650 | 26,832 | 19,350 | 20 K to 19.4 K (-3.25 %) |
Feb 21 2013 | BCP | BALCHEM CORP | FITZPATRICK FRANK | CFO | Option Exercise | A | 38.10 | 10,281 | 391,706 | 10,281 | |
Feb 21 2013 | BCP | BALCHEM CORP | FITZPATRICK FRANK | CFO | Grant | A | 0.00 | 2,456 | 0 | 53,448 | 51 K to 53.4 K (+4.82 %) |
Feb 21 2013 | BCP | BALCHEM CORP | PUTNAM DANA E. | Vice President and ... | Option Exercise | A | 38.10 | 13,000 | 495,300 | 13,000 | |
Feb 21 2013 | BCP | BALCHEM CORP | PUTNAM DANA E. | Vice President and ... | Grant | A | 0.00 | 1,617 | 0 | 44,622 | 43 K to 44.6 K (+3.76 %) |
Feb 21 2013 | BCP | BALCHEM CORP | LUDWIG DAVID F | VP/Gen Mgr/ARC Spec ... | Option Exercise | A | 38.10 | 9,134 | 348,005 | 9,134 | |
Feb 21 2013 | BCP | BALCHEM CORP | LUDWIG DAVID F | VP/Gen Mgr/ARC Spec ... | Grant | A | 0.00 | 3,081 | 0 | 32,490 | 35.6 K to 32.5 K (-8.66 %) |
Feb 21 2013 | BCP | BALCHEM CORP | Houston Matthew David | General Counsel/Sec ... | Option Exercise | A | 38.10 | 4,346 | 165,583 | 4,346 | |
Feb 21 2013 | BCP | BALCHEM CORP | Houston Matthew David | General Counsel/Sec ... | Grant | A | 0.00 | 1,466 | 0 | 11,946 | 13.4 K to 11.9 K (-10.93 %) |
Jan 17 2013 | BCP | BALCHEM CORP | ROSSI DINO A | President & CEO | Sell | S | 36.28 | 14,342 | 520,328 | 130,733 | 145.1 K to 130.7 K (-9.89 %) |
Jan 17 2013 | BCP | BALCHEM CORP | ROSSI DINO A | President & CEO | Buy | M | 5.85 | 14,342 | 83,901 | 145,075 | 130.7 K to 145.1 K (+10.97 %) |
Jan 17 2013 | BCP | BALCHEM CORP | ROSSI DINO A | President & CEO | Sell | S | 36.43 | 32,050 | 1,167,582 | 130,733 | 162.8 K to 130.7 K (-19.69 %) |
Jan 17 2013 | BCP | BALCHEM CORP | ROSSI DINO A | President & CEO | Buy | M | 5.85 | 32,050 | 187,493 | 162,783 | 130.7 K to 162.8 K (+24.52 %) |
Dec 20 2012 | BCP | BALCHEM CORP | ROSSI DINO A | President & CEO | Sell | S | 35.19 | 15,489 | 545,058 | 130,733 | 146.2 K to 130.7 K (-10.59 %) |
Dec 20 2012 | BCP | BALCHEM CORP | ROSSI DINO A | President & CEO | Buy | M | 5.85 | 15,489 | 90,611 | 146,222 | 130.7 K to 146.2 K (+11.85 %) |
Dec 20 2012 | BCP | BALCHEM CORP | ROSSI DINO A | President & CEO | Sell | S | 35.19 | 6,153 | 216,524 | 130,733 | 136.9 K to 130.7 K (-4.49 %) |
Dec 20 2012 | BCP | BALCHEM CORP | ROSSI DINO A | President & CEO | Buy | M | 4.51 | 6,153 | 27,750 | 136,886 | 130.7 K to 136.9 K (+4.71 %) |
Dec 20 2012 | BCP | BALCHEM CORP | ROSSI DINO A | President & CEO | Sell | S | 35.65 | 14,543 | 518,458 | 130,733 | 145.3 K to 130.7 K (-10.01 %) |
Dec 20 2012 | BCP | BALCHEM CORP | ROSSI DINO A | President & CEO | Buy | M | 4.51 | 14,543 | 65,589 | 145,276 | 130.7 K to 145.3 K (+11.12 %) |
Dec 18 2012 | BCP | BALCHEM CORP | MCMILLAN EDWARD | Director | Sell | S | 35.50 | 13,000 | 461,500 | 35,705 | 48.7 K to 35.7 K (-26.69 %) |
Dec 14 2012 | BCP | BALCHEM CORP | TELEVANTOS JOHN Y | Director | Grant | A | 0.00 | 2,799 | 0 | 50,257 | 47.5 K to 50.3 K (+5.90 %) |
Dec 14 2012 | BCP | BALCHEM CORP | COOMBS PAUL D | Director | Grant | A | 0.00 | 2,799 | 0 | 14,293 | 11.5 K to 14.3 K (+24.35 %) |
Dec 14 2012 | BCP | BALCHEM CORP | WEDRAL ELAINE R | Director | Grant | A | 0.00 | 2,799 | 0 | 48,757 | 46 K to 48.8 K (+6.09 %) |
Dec 14 2012 | BCP | BALCHEM CORP | MCMILLAN EDWARD | Director | Grant | A | 0.00 | 2,799 | 0 | 48,705 | 45.9 K to 48.7 K (+6.10 %) |
Dec 14 2012 | BCP | BALCHEM CORP | Premdas Perry W | Director | Grant | A | 0.00 | 2,799 | 0 | 40,432 | 37.6 K to 40.4 K (+7.44 %) |
Dec 14 2012 | BCP | BALCHEM CORP | Fischer David B | Director | Grant | A | 0.00 | 2,799 | 0 | 9,293 | 6.5 K to 9.3 K (+43.10 %) |
Dec 12 2012 | BCP | BALCHEM CORP | Houston Matthew David | General Counsel/Sec ... | Payment of Exercise | F | 35.89 | 541 | 19,416 | 10,430 | 11 K to 10.4 K (-4.93 %) |
Dec 12 2012 | BCP | BALCHEM CORP | Backus William A. | Chief Accounting Of ... | Payment of Exercise | F | 35.89 | 541 | 19,416 | 10,002 | 10.5 K to 10 K (-5.13 %) |
Dec 12 2012 | BCP | BALCHEM CORP | FITZPATRICK FRANK | CFO | Payment of Exercise | F | 35.89 | 2,761 | 99,092 | 50,782 | 53.5 K to 50.8 K (-5.16 %) |
Dec 12 2012 | BCP | BALCHEM CORP | LUDWIG DAVID F | VP/Gen Mgr/ARC Spec ... | Payment of Exercise | F | 35.89 | 1,351 | 48,487 | 29,260 | 30.6 K to 29.3 K (-4.41 %) |
Dec 12 2012 | BCP | BALCHEM CORP | ROSSI DINO A | President & CEO | Payment of Exercise | F | 35.89 | 6,902 | 247,713 | 130,733 | 137.6 K to 130.7 K (-5.01 %) |
Dec 12 2012 | BCP | BALCHEM CORP | PUTNAM DANA E. | Vice President and ... | Payment of Exercise | F | 35.89 | 2,162 | 77,594 | 42,923 | 45.1 K to 42.9 K (-4.80 %) |
Nov 09 2012 | BCP | BALCHEM CORP | COOMBS PAUL D | Director | Buy | P | 32.25 | 1,000 | 32,250 | 11,494 | 10.5 K to 11.5 K (+9.53 %) |
Nov 09 2012 | BCP | BALCHEM CORP | COOMBS PAUL D | Director | Buy | P | 32.45 | 5,000 | 162,230 | 10,494 | 5.5 K to 10.5 K (+91.01 %) |
Oct 18 2012 | BCP | BALCHEM CORP | ROSSI DINO A | President & CEO | Sell | S | 35.19 | 8,543 | 300,628 | 137,621 | 146.2 K to 137.6 K (-5.84 %) |
Oct 18 2012 | BCP | BALCHEM CORP | ROSSI DINO A | President & CEO | Buy | M | 4.51 | 8,543 | 38,529 | 146,164 | 137.6 K to 146.2 K (+6.21 %) |
Oct 18 2012 | BCP | BALCHEM CORP | ROSSI DINO A | President & CEO | Sell | S | 35.02 | 6,611 | 231,517 | 137,621 | 144.2 K to 137.6 K (-4.58 %) |
Oct 18 2012 | BCP | BALCHEM CORP | ROSSI DINO A | President & CEO | Buy | M | 4.51 | 6,611 | 29,816 | 144,232 | 137.6 K to 144.2 K (+4.80 %) |
Sep 20 2012 | BCP | BALCHEM CORP | PUTNAM DANA E. | VP and General Mana ... | Grant | A | 0.00 | 10,000 | 0 | 45,085 | 35.1 K to 45.1 K (+28.50 %) |
Sep 20 2012 | BCP | BALCHEM CORP | ROSSI DINO A | President & CEO | Sell | S | 36.88 | 14,700 | 542,136 | 137,621 | 152.3 K to 137.6 K (-9.65 %) |
Sep 20 2012 | BCP | BALCHEM CORP | ROSSI DINO A | President & CEO | Buy | M | 4.51 | 14,700 | 66,297 | 152,321 | 137.6 K to 152.3 K (+10.68 %) |
Sep 20 2012 | BCP | BALCHEM CORP | ROSSI DINO A | President & CEO | Sell | S | 37.06 | 14,700 | 544,782 | 137,621 | 152.3 K to 137.6 K (-9.65 %) |
Sep 20 2012 | BCP | BALCHEM CORP | ROSSI DINO A | President & CEO | Buy | M | 4.51 | 14,700 | 66,297 | 152,321 | 137.6 K to 152.3 K (+10.68 %) |
Jun 18 2012 | BCP | BALCHEM CORP | Backus William A. | CAO and Assistant T ... | Option Exercise | A | 31.02 | 2,500 | 77,550 | 2,500 | |
Mar 01 2012 | BCP | BALCHEM CORP | LUDWIG DAVID F | VP/Gen Mgr/ARC Spec ... | Option Exercise | A | 29.06 | 12,970 | 376,908 | 12,970 | |
Mar 01 2012 | BCP | BALCHEM CORP | LUDWIG DAVID F | VP/Gen Mgr/ARC Spec ... | Grant | A | 0.00 | 4,142 | 0 | 30,368 | 26.2 K to 30.4 K (+15.79 %) |
Mar 01 2012 | BCP | BALCHEM CORP | Backus William A. | CAO, Assistant Trea ... | Option Exercise | A | 29.06 | 12,000 | 348,720 | 12,000 | |
Mar 01 2012 | BCP | BALCHEM CORP | Backus William A. | CAO, Assistant Trea ... | Grant | A | 0.00 | 2,500 | 0 | 10,309 | 7.8 K to 10.3 K (+32.01 %) |
Mar 01 2012 | BCP | BALCHEM CORP | ROSSI DINO A | President & CEO | Option Exercise | A | 29.06 | 45,672 | 1,327,228 | 45,672 | |
Mar 01 2012 | BCP | BALCHEM CORP | ROSSI DINO A | President & CEO | Grant | A | 0.00 | 14,585 | 0 | 137,507 | 122.9 K to 137.5 K (+11.87 %) |
Mar 01 2012 | BCP | BALCHEM CORP | Houston Matthew David | General Counsel/Sec ... | Option Exercise | A | 29.06 | 5,835 | 169,565 | 5,835 | |
Mar 01 2012 | BCP | BALCHEM CORP | Houston Matthew David | General Counsel/Sec ... | Grant | A | 0.00 | 1,867 | 0 | 10,739 | 8.9 K to 10.7 K (+21.04 %) |
Mar 01 2012 | BCP | BALCHEM CORP | FITZPATRICK FRANK | CFO | Option Exercise | A | 29.06 | 14,935 | 434,011 | 14,935 | |
Mar 01 2012 | BCP | BALCHEM CORP | FITZPATRICK FRANK | CFO | Grant | A | 0.00 | 4,769 | 0 | 53,325 | 48.6 K to 53.3 K (+9.82 %) |
Jan 12 2012 | BCP | BALCHEM CORP | ROSSI DINO A | President & CEO | Payment of Exercise | F | 41.53 | 9,407 | 390,673 | 122,678 | 132.1 K to 122.7 K (-7.12 %) |
Jan 12 2012 | BCP | BALCHEM CORP | ROSSI DINO A | President & CEO | Sell | S | 41.51 | 18,000 | 747,162 | 132,085 | 150.1 K to 132.1 K (-11.99 %) |
Jan 12 2012 | BCP | BALCHEM CORP | ROSSI DINO A | President & CEO | Buy | M | 4.51 | 18,000 | 81,180 | 150,085 | 132.1 K to 150.1 K (+13.63 %) |
Jan 12 2012 | BCP | BALCHEM CORP | ROSSI DINO A | President & CEO | Sell | S | 41.56 | 18,000 | 748,093 | 132,085 | 150.1 K to 132.1 K (-11.99 %) |
Jan 12 2012 | BCP | BALCHEM CORP | ROSSI DINO A | President & CEO | Buy | M | 4.51 | 18,000 | 81,180 | 150,085 | 132.1 K to 150.1 K (+13.63 %) |
Jan 12 2012 | BCP | BALCHEM CORP | FITZPATRICK FRANK | CFO | Payment of Exercise | F | 41.53 | 2,535 | 105,279 | 48,808 | 51.3 K to 48.8 K (-4.94 %) |
Jan 12 2012 | BCP | BALCHEM CORP | LUDWIG DAVID F | VP/Gen Mgr/ARC Spec ... | Payment of Exercise | F | 41.53 | 1,454 | 60,385 | 26,121 | 27.6 K to 26.1 K (-5.27 %) |
Jan 12 2012 | BCP | BALCHEM CORP | Houston Matthew David | General Counsel/Sec ... | Payment of Exercise | F | 41.53 | 906 | 37,626 | 8,845 | 9.8 K to 8.8 K (-9.29 %) |
Dec 21 2011 | BCP | BALCHEM CORP | FITZPATRICK FRANK | CFO | Sell | S | 40.41 | 20,000 | 808,228 | 50,718 | 70.7 K to 50.7 K (-28.28 %) |
Dec 21 2011 | BCP | BALCHEM CORP | FITZPATRICK FRANK | CFO | Buy | M | 5.85 | 20,000 | 117,000 | 70,718 | 50.7 K to 70.7 K (+39.43 %) |
Dec 21 2011 | BCP | BALCHEM CORP | FITZPATRICK FRANK | CFO | Sell | S | 40.25 | 10,000 | 402,483 | 50,718 | 60.7 K to 50.7 K (-16.47 %) |
Dec 21 2011 | BCP | BALCHEM CORP | FITZPATRICK FRANK | CFO | Buy | M | 5.85 | 10,000 | 58,500 | 60,718 | 50.7 K to 60.7 K (+19.72 %) |
Dec 12 2011 | BCP | BALCHEM CORP | Backus William A. | CAO and Assistant T ... | Sell | S | 41.82 | 5,612 | 234,702 | 7,706 | 13.3 K to 7.7 K (-42.14 %) |
Dec 12 2011 | BCP | BALCHEM CORP | Backus William A. | CAO and Assistant T ... | Buy | M | 13.61 | 5,612 | 76,379 | 13,318 | 7.7 K to 13.3 K (+72.83 %) |
Dec 12 2011 | BCP | BALCHEM CORP | Backus William A. | CAO and Assistant T ... | Sell | S | 41.58 | 2,888 | 120,082 | 7,706 | 10.6 K to 7.7 K (-27.26 %) |
Dec 12 2011 | BCP | BALCHEM CORP | Backus William A. | CAO and Assistant T ... | Buy | M | 13.61 | 2,888 | 39,306 | 10,594 | 7.7 K to 10.6 K (+37.48 %) |
Dec 08 2011 | BCP | BALCHEM CORP | MCMILLAN EDWARD | Director | Sell | S | 41.86 | 4,646 | 194,478 | 45,906 | 50.6 K to 45.9 K (-9.19 %) |
Dec 08 2011 | BCP | BALCHEM CORP | MCMILLAN EDWARD | Director | Buy | M | 4.75 | 4,646 | 22,069 | 50,552 | 45.9 K to 50.6 K (+10.12 %) |
Dec 08 2011 | BCP | BALCHEM CORP | MCMILLAN EDWARD | Director | Sell | S | 41.92 | 18,883 | 791,645 | 45,906 | 64.8 K to 45.9 K (-29.15 %) |
Dec 08 2011 | BCP | BALCHEM CORP | MCMILLAN EDWARD | Director | Buy | M | 4.75 | 18,883 | 89,694 | 64,789 | 45.9 K to 64.8 K (+41.13 %) |
Dec 05 2011 | BCP | BALCHEM CORP | MCMILLAN EDWARD | Director | Grant | A | 0.00 | 2,418 | 0 | 45,906 | 43.5 K to 45.9 K (+5.56 %) |
Dec 02 2011 | BCP | BALCHEM CORP | Fischer David B | Director | Grant | A | 0.00 | 2,418 | 0 | 6,494 | 4.1 K to 6.5 K (+59.32 %) |
Dec 02 2011 | BCP | BALCHEM CORP | Backus William A. | Chief Accounting Of ... | Sell | S | 41.43 | 3,500 | 145,005 | 7,706 | 11.2 K to 7.7 K (-31.23 %) |
Dec 02 2011 | BCP | BALCHEM CORP | Backus William A. | Chief Accounting Of ... | Buy | M | 13.61 | 3,500 | 47,635 | 11,206 | 7.7 K to 11.2 K (+45.42 %) |
Dec 02 2011 | BCP | BALCHEM CORP | Backus William A. | Chief Accounting Of ... | Sell | S | 41.43 | 4,400 | 182,292 | 7,706 | 12.1 K to 7.7 K (-36.35 %) |
Dec 02 2011 | BCP | BALCHEM CORP | Backus William A. | Chief Accounting Of ... | Buy | M | 11.87 | 4,400 | 52,228 | 12,106 | 7.7 K to 12.1 K (+57.10 %) |
Dec 02 2011 | BCP | BALCHEM CORP | Backus William A. | Chief Accounting Of ... | Sell | S | 41.50 | 100 | 4,150 | 7,706 | 7.8 K to 7.7 K (-1.28 %) |
Dec 02 2011 | BCP | BALCHEM CORP | Backus William A. | Chief Accounting Of ... | Buy | M | 11.87 | 100 | 1,187 | 7,806 | 7.7 K to 7.8 K (+1.30 %) |
Dec 02 2011 | BCP | BALCHEM CORP | Premdas Perry W | Director | Grant | A | 0.00 | 2,418 | 0 | 37,633 | 35.2 K to 37.6 K (+6.87 %) |
Dec 02 2011 | BCP | BALCHEM CORP | WEDRAL ELAINE R | Director | Grant | A | 0.00 | 2,418 | 0 | 45,958 | 43.5 K to 46 K (+5.55 %) |
Dec 02 2011 | BCP | BALCHEM CORP | WEDRAL ELAINE R | Director | Sell | S | 40.50 | 15,000 | 607,500 | 43,450 | 58.5 K to 43.5 K (-25.66 %) |
Dec 02 2011 | BCP | BALCHEM CORP | WEDRAL ELAINE R | Director | Buy | M | 7.32 | 15,000 | 109,800 | 58,540 | 43.5 K to 58.5 K (+34.45 %) |
Dec 02 2011 | BCP | BALCHEM CORP | TELEVANTOS JOHN Y | Director | Grant | A | 0.00 | 2,418 | 0 | 47,458 | 45 K to 47.5 K (+5.37 %) |
Dec 02 2011 | BCP | BALCHEM CORP | COOMBS PAUL D | Director | Grant | A | 0.00 | 2,418 | 0 | 5,494 | 3.1 K to 5.5 K (+78.61 %) |
Nov 29 2011 | BCP | BALCHEM CORP | WEDRAL ELAINE R | Director | Sell | S | 39.50 | 4,950 | 195,525 | 45,040 | 50 K to 45 K (-9.90 %) |
Nov 29 2011 | BCP | BALCHEM CORP | WEDRAL ELAINE R | Director | Buy | M | 7.32 | 4,950 | 36,234 | 49,990 | 45 K to 50 K (+10.99 %) |
Nov 29 2011 | BCP | BALCHEM CORP | WEDRAL ELAINE R | Director | Sell | S | 39.35 | 5,050 | 198,718 | 45,040 | 50.1 K to 45 K (-10.08 %) |
Nov 29 2011 | BCP | BALCHEM CORP | WEDRAL ELAINE R | Director | Buy | M | 7.32 | 5,050 | 36,966 | 50,090 | 45 K to 50.1 K (+11.21 %) |
Sep 02 2011 | BCP | BALCHEM CORP | TELEVANTOS JOHN Y | Director | Sell | S | 41.50 | 3,000 | 124,500 | 45,040 | 48 K to 45 K (-6.24 %) |